TORONTO, May 17, 2024
/PRNewswire/ -- Visionary Holdings Inc. (the "Company") (NASDAQ:
GV), a private education provider with technology of artificial
intelligence and life science on the cutting edge, with
subsidiaries in Canada and market
partners in China, today announced
the Company and Red Sun Group, a top 500 company in China, are collaborating to jointly invest in
establishing a life sciences industry conglomerate in Toronto. This initiative aims to contribute
globally to achieving the mission of "health, happiness, beauty,
and longevity" for humanity, making it a top contributor in
preventive medicine and natural medicine.
Visionary Group and Red Sun Group, a top 500 company in
China, are collaborating to
jointly invest in establishing a life sciences industry
conglomerate in Toronto. This
conglomerate aims to become the world's largest platform for
nicotinamide (whitening) and anti-aging NMN (nicotinamide
mononucleotide) industries. Leveraging Red Sun Group's globally
leading nicotinamide and NMN raw material base and technological
platform, Visionary Group plans to establish a complete industry
chain business system from raw materials to functional foods,
skincare products, functional animal health products, and future
medical terminal products. These products serve global cosmetics,
food manufacturing, animal products, pharmaceutical, and medical
institutions, as well as end customers.
Harvard University scientist
David Sinclair confirms the
life-extending effect of NMN
Visionary Group cooperates with Red Sun Group, a Fortune 500
company in China, to establish a
cooperation project of a life science industry group in
Toronto, which has the core of the
health care industry:
1. Biotechnology innovation and bio-patented
technology:
Red Sun Group has the world's leading nicotine and NMN raw material
production and technology platforms, and can provide high-quality
products through innovation, which is important for promoting the
life science industry and related functionalities The development
of food and health products is crucial.
2. Capabilities and conditions for high cross-border
integration of the health industry chain:
By establishing a complete industrial chain from raw materials to
final products, we can not only enhance the competitiveness of
high-quality products, but also fully control production costs and
quality, thereby more effectively meeting
global and global needs. Canada's
vast market demand.
3. Accurate target market demand positioning and
expansion:
The group's products serve many fields such as cosmetics, food
manufacturing, animal products, pharmaceuticals and medical
institutions. Its diversified market positioning helps expand the
target market and customer base to increase market share.
4. Global trends and health needs:
Anti-aging and whitening products are in line with the current
demand trends of global consumers, especially for customer groups
who pursue healthy quality of life and appearance care. This can
ensure the core value and continued sustainability of the products
in the market need.
5. Transnational research and development (R&D):
Companies invest in research and development of new products and
technologies, which not only helps maintain product innovation and
competitiveness, but is also a key factor in stabilizing and
expanding market positions.
6. Sino-Canadian international cooperation:
This kind of transnational cooperation is essential for
strengthening international business relations and expanding global
markets, and can also enhance the international image of corporate
brands.
7. Sustainability contributes to human health and positive
corporate social responsibility:
Corporate behavior consistent with sustainable development
increases the company's awareness of the environment and its
investment in social responsibility, which helps enhance the
corporate image and attract investors .
Cross-border cooperation projects can bring high-growth
opportunities driven by biotechnology innovation to participating
group companies, and have the potential to shape the future global
trends in related health industries.
NMN Nicotinamide Mononucleotide Market Size and
Forecast
The nicotinamide mononucleotide market size is US$5 billion in 2023 and is expected to reach
US$12.93 billion by 2031, with a
compound annual growth rate from 2024 to 2031 of 9.1%. and play an
important role in the market.
Nicotinamide mononucleotide (NMN)'s potential health benefits
and growing use in the anti-aging and longevity fields are driving
the phenomenal growth of the market. Nicotinamide adenine
dinucleotide (NMN) is the precursor of NAD+ and is essential for
cellular energy synthesis and DNA repair processes. Research on the
importance of NMN in supporting cellular resiliency and health
continues, generating strong interest from customers looking for
longevity solutions. Furthermore, the market for NMN supplements is
growing and is expected to continue to grow in the foreseeable
future due to factors such as the aging world population and
people's desire for a better lifestyle.
Nicotinamide mononucleotide (NMN) market is expanding owing to
many important parameters. First, growing consumer awareness of
NMN's possible anti-aging and life-extending effects is driving
demand for NMN supplements. Secondly, more and more studies have
demonstrated the function of NMN in DNA repair pathways and
cellular energy metabolism, encouraging its use in the health and
wellness industry. Thirdly, the market is growing as age-related
diseases are becoming more common as the elderly population is
seeking preventive healthcare measures. Additionally, endorsements
from celebrities and medical professionals have further enhanced
consumer confidence in NMN supplements, thereby driving market
expansion. As the search for healthy aging solutions continues to
heat up, there is still plenty of room for growth in the NMN
market.
Mechanism of Action of NMN
Increased Nicotinamide Mononucleotide (NMN), a precursor to NAD,
promotes axonal regeneration post-injury.
NMN exhibits novel physiological functions in mammals, unveiling
unexpected links between cancer chemotherapy strategies and axonal
disease treatments.
NMN has novel physiological functions in mammals and reveals
unexpected connections between new strategies for cancer
chemotherapy and the treatment of axonopathies .
Reverse Aging: Harvard Scientist Dr. David Sinclair on NMN and Anti-Aging
Supplements
Dynamic of Nicotinamide Mononucleotide (NMN) Market
Market Drivers:
Rising consumer awareness of anti-aging benefits: Increasing
consumer awareness of the potential anti-aging benefits of NMN is
driving demand for NMN supplements.
Extensive research supports NMN's health benefits: Extensive
scientific research emphasizes NMN's role in cellular energy
metabolism and DNA repair mechanisms, driving its adoption in the
health and wellness sector.
Increasing prevalence of age-related diseases: The increasing
prevalence of age-related diseases, coupled with global population
aging, is driving demand for preventive healthcare measures
(including NMN supplements).
Endorsement from healthcare professionals and celebrities:
Endorsement and recommendations from healthcare professionals and
celebrities are enhancing consumer confidence in NMN supplements,
driving market growth.
Market Challenges:
Regulatory barriers and compliance issues: Regulatory barriers
and compliance requirements related to the marketing and
distribution of NMN supplements pose challenges for market entry
and expansion.
High production costs: High production costs associated with
manufacturing NMN supplements (including purification and quality
control processes) may affect pricing and profit margins.
Limited clinical evidence: Despite promising research results,
limited clinical evidence supporting the efficacy and safety of NMN
supplements may hinder widespread adoption by consumers and
healthcare professionals.
Competition from alternative anti-aging solutions: Competition
from alternative anti-aging solutions (such as other NAD+
precursors and dietary supplements) presents challenges for market
penetration and differentiation.
Market Trends:
Focus on personalized nutrition: The trend towards personalized
nutrition and health solutions is driving the development of
customized NMN formulations tailored to individual health needs and
preferences.
Expansion of distribution channels: The expansion of
distribution channels, including online platforms and specialty
health stores, is widening access to NMN supplements, driving
market growth.
Product formulation innovation: Market participants are
innovating new product formulations, such as NMN capsules, powders,
and sublingual tablets, to enhance bioavailability and ease of
consumption.
Integration of NMN in beauty and cosmetics: The integration of
NMN in beauty and cosmetic products, due to its anti-aging
properties, reflects the growing trend towards holistic health and
beauty solutions.
The NMN market report compiles complex information targeting
specific niche markets, providing an in-depth overview of specific
industries or across different sectors. This comprehensive report
combines quantitative and qualitative analysis, predicting trends
from 2023 to 2031. It utilizes industry terminologies, key players,
consumer behavior, and the national economic, political, and social
landscape.
The thorough segmentation of the report ensures a comprehensive
analysis of the market from various perspectives. This detailed
report delves into key areas, extensively examining market
segmentation, market prospects, competitive landscapes, and company
profiles. These sections provide detailed insights from different
angles, considering factors such as end-use industries, product or
service categorizations, and other relevant sub-segments aligned
with current market conditions. This comprehensive analysis aids in
optimizing ongoing marketing strategies.
In the market outlook section, a deep analysis of market
evolution is conducted, examining growth drivers, barriers,
opportunities, and challenges. This involves a thorough exploration
of the Porter's Five Forces framework, macroeconomic assessments,
value chain reviews, and comprehensive pricing analysis—all of
which actively shape current market dynamics and are expected to
continue influencing the market during the forecast period.
Internal market factors are elucidated through drivers and
constraints, while external influences shaping the market are
detailed through opportunities and challenges. Additionally, this
section provides valuable insights into popular trends influencing
emerging business ventures and investment opportunities.
About Visionary Holdings Inc.
Visionary Holdings Inc. headquartered in Toronto, Canada, a private education provider
with technology of artificial intelligence and life science on the
cutting edge, with subsidiaries in Canada and market partners in China. The Company aims to provide access to
secondary, college, undergraduate and graduate and vocational
education to students in Canada
through technological innovation so that more people can learn,
grow and succeed to their full potential. As a fully integrated
provider of educational programs and services in Canada, the Company has been serving and will
continue to serve both Canadian and international students. For
more information, visit the Company's website at
https://ir.visiongroupca.com/.
Forward-Looking Statements
All statements other than statements of historical fact in this
announcement are forward-looking statements. These forward-looking
statements involve known and unknown risks and uncertainties and
are based on the Company's current expectations and projections
about future events that the Company believes may affect its
financial condition, results of operations, business strategy and
financial needs. Investors can identify these forward-looking
statements by words or phrases such as "believes," "expects,"
"anticipates," "estimates," "intends," "would," "continue,"
"should," "may," or similar expressions. The Company undertakes no
obligation to update or revise publicly any forward-looking
statements to reflect subsequent occurring events or circumstances,
or changes in its expectations, except as may be required by law.
Although the Company believes that the expectations expressed in
these forward-looking statements are reasonable, it cannot assure
you that such expectations will turn out to be correct, and the
Company cautions investors that actual results may differ
materially from the anticipated results and encourages investors to
review other factors that may affect its future results in the
Company's registration statement and in its other filings with the
SEC.
For more information, please contact:
Visionary Holdings Inc.
Investor Relations Department
rachelxiao@farvision.ca
View original
content:https://www.prnewswire.com/news-releases/gv-announces-cooperation-with-top-500-company-in-china-302148796.html
SOURCE Visionary Holdings Inc.